Aceragen, Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Aceragen, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q1 2023.
  • Aceragen, Inc. Common Stock, Shares Authorized for the quarter ending March 31, 2023 was 140M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 140M 0 0% Mar 31, 2023 10-Q 2023-06-29
Q4 2022 140M 0 0% Dec 31, 2022 10-Q 2023-06-29
Q3 2022 140M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 140M 0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 140M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 140M 0 0% Dec 31, 2021 10-K 2023-04-13
Q3 2021 140M 0 0% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 140M 0 0% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 140M +70M +100% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 140M 0 0% Dec 31, 2020 10-K 2022-03-31
Q3 2020 140M +70M +100% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 140M +70M +100% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 70M 0 0% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 140M +70M +100% Dec 31, 2019 10-Q 2022-11-14
Q3 2019 70M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 70M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 70M -210M -75% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 70M 0 0% Dec 31, 2018 10-K 2020-03-12
Q3 2018 70M -210M -75% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 70M -210M -75% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 280M 0 0% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 70M -210M -75% Dec 31, 2017 10-K 2019-03-06
Q3 2017 280M 0 0% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 280M 0 0% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 280M 0 0% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 280M 0 0% Dec 31, 2016 10-K 2018-03-07
Q3 2016 280M 0 0% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 280M 0 0% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 280M 0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 280M 0 0% Dec 31, 2015 10-K 2017-03-15
Q3 2015 280M 0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 280M 0 0% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 280M 0 0% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 280M 0 0% Dec 31, 2014 10-K 2016-03-10
Q3 2014 280M 0 0% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 280M +140M +100% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 280M +140M +100% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 280M +140M +100% Dec 31, 2013 10-K 2015-03-12
Q3 2013 280M +140M +100% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 140M 0 0% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 140M +70M +100% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 140M +70M +100% Dec 31, 2012 10-K 2014-03-13
Q3 2012 140M +70M +100% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 140M +70M +100% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 70M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 70M 0 0% Dec 31, 2011 10-K 2013-03-11
Q3 2011 70M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 70M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 70M Dec 31, 2010 10-Q 2011-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.